Phillip Barnette

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 597 citations · Full text

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

Richard H. Ko, Lingyun Ji, Phillip Barnette et al. · Journal of Clinical Oncology · 2009 · 273 citations · Full text

Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors

William D. Tap, George D. Demetri, Phillip Barnette et al. · Journal of Clinical Oncology · 2012 · 217 citations

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Matthew F. Gorman, Lingyun Ji, Richard H. Ko et al. · Pediatric Blood & Cancer · 2010 · 111 citations

Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Kimberly Davies, Matthew J. Barth, Saro H. Armenian et al. · Journal of the National Comprehensive Cancer Network · 2020 · 67 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Pediatric Epidemiology +13